Article metrics

PDF
Efficacy and adverse events of aflibercept, ranibizumab and bevacizumab in age-related macular degeneration: a trade-off analysis

Statistics from Altmetric.com

Online download statistics by month:

AbstractFullPDF
Jun 201447412111
Jul 20141111034
Aug 20144307
Sep 20147129
Oct 2014187160162
Nov 20141658572
Dec 20141146671
Jan 201589480159
Feb 2015101474171
Mar 20154136374
Apr 20151985167
May 20151845555
Jun 20151573144
Jul 20151152425
Aug 20151293949
Sep 2015912733
Oct 2015701424
Nov 20151083548
Dec 2015822221
Jan 20161064045
Feb 2016822428
Mar 2016683229
Apr 2016871829
May 2016621311
Jun 2016651221
Jul 2016601115
Aug 2016571412
Sep 2016811014
Oct 2016621613
Nov 2016432217
Dec 2016361114
Jan 20171022121
Feb 2017711215
Mar 2017542521
Apr 20171072919
May 20172603321
Jun 2017312178
Jul 20172282221
Aug 20171722516
Sep 20173192214
Total705412791640